Your browser doesn't support javascript.
loading
Development and validation of an RNA sequencing panel for gene fusions in soft tissue sarcoma.
Hu, Wanming; Yuan, Li; Zhang, Xinke; Ni, Yang; Hong, Dongchun; Wang, Zhicai; Li, Xiaomin; Ling, Yuan; Zhang, Chao; Deng, Wanglong; Tian, Minqi; Ding, Ran; Song, Chao; Li, Jianmin; Zhang, Xing.
Affiliation
  • Hu W; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Yuan L; Department of Pathology, Guangzhou Women and Children's Medical Center, Guangzhou, China.
  • Zhang X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Ni Y; State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China.
  • Hong D; Department of Medicine, Nanjing Simcere Medical Laboratory Science Co., Ltd, Nanjing, China.
  • Wang Z; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Medical Melanoma and Sarcoma, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Li X; Department of General Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research &, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
  • Ling Y; State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China.
  • Zhang C; State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China.
  • Deng W; State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China.
  • Tian M; State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China.
  • Ding R; State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China.
  • Song C; State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China.
  • Li J; State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China.
  • Zhang X; Department of Medicine, Nanjing Simcere Medical Laboratory Science Co., Ltd, Nanjing, China.
Cancer Sci ; 113(5): 1843-1854, 2022 May.
Article in En | MEDLINE | ID: mdl-35238118
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Sarcoma / Soft Tissue Neoplasms Limits: Humans Language: En Journal: Cancer Sci Year: 2022 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Sarcoma / Soft Tissue Neoplasms Limits: Humans Language: En Journal: Cancer Sci Year: 2022 Type: Article Affiliation country: China